GOVERNANCE

Partners

The Translational Research Institute (TRI) is a collaboration between four major partners: The University of Queensland's Diamantina Institute (UQDI) and School of Medicine; the Queenland University of Technology's Institute of Health and Biomedical Innovation (IHBI); Queensland Health's Princess Alexandra Hospital (PAH) and Mater Research.
> More info

Funding Partners

TRI is supported by a grant from the Australian Government and funding from the  Queensland Government; Atlantic Philanthropies; The University of Queensland; Queensland University of Technology; and Mater Research. 
> More info

Board of Directors

The TRI Board of Directors is made up of nomiated representatives from our four shareholders and an independent Chair. 
> More info

Executive Leadership Team

The TRI Executive Leadership Team (ELT) is lead by the CEO and includes Directors from Corporate, Legal, Building Operations, Marketing and Communications, and the Research and Clinical Interface. 
> More info

Policies & Procedures

Information about work place policy, grievance procedures and privacy can be found in this section. 
> More info